Allegro Ophthalmics Overview
- Year Founded
-
2011
- Status
-
Private
- Employees
-
6
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$30.2M
- Investors
-
4
Allegro Ophthalmics General Information
Description
Operator of an ophthalmic biopharmaceutical company intended to redefine the retina space with integrin inhibition therapy. The company's lead investigational drug is a broad-spectrum integrin inhibitor, that downregulates oxidative stress upstream, at its source and simultaneously affects all four pathways of oxidative stress that contribute to retinal diseases such as diabetic macular edema (DME) and nonexudative age-related macular degeneration, enabling ophthalmologists to treat ocular diseases.
Contact Information
Website
www.allegroeye.comCorporate Office
- 31473 Rancho Viejo Road
- Suite 204
- San Juan Capistrano, CA 92675
- United States
Corporate Office
- 31473 Rancho Viejo Road
- Suite 204
- San Juan Capistrano, CA 92675
- United States
Allegro Ophthalmics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Later Stage VC | 12-Oct-2021 | $30.2M | Completed | Clinical Trials - Phase 2 | ||
| 6. Accelerator/Incubator | 19-Sep-2017 | Completed | Clinical Trials - Phase 1 | |||
| 5. Later Stage VC | 09-Jul-2017 | Completed | Clinical Trials - Phase 1 | |||
| 4. Grant | 03-Feb-2015 | Completed | Clinical Trials - Phase 1 | |||
| 3. Later Stage VC (Series C) | 26-Jan-2015 | Completed | Clinical Trials - Phase 1 | |||
| 2. Early Stage VC (Series B) | 02-May-2013 | $10M | $11.5M | Completed | Clinical Trials - Phase 1 | |
| 1. Angel (individual) | 01-Apr-2012 | $1.5M | $1.5M | Completed | Clinical Trials - Phase 1 |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Allegro Ophthalmics Comparisons
Industry
Financing
Details
Allegro Ophthalmics Competitors (33)
One of Allegro Ophthalmics’s 33 competitors is Stuart Therapeutics, a Venture Capital-Backed company based in Stuart, FL.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Stuart Therapeutics | Venture Capital-Backed | Stuart, FL | ||||
| Inovio Pharmaceuticals | Corporation | Plymouth Meeting, PA | ||||
| Kala Bio | Formerly VC-backed | Arlington, MA | ||||
| ONL Therapeutics | Venture Capital-Backed | Ann Arbor, MI | ||||
| Foventa Therapeutics | Venture Capital-Backed | Cambridge, United Kingdom |
Allegro Ophthalmics Patents
Allegro Ophthalmics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2022529823-A | Compositions and methods that can be used to treat dry eye | Pending | 22-Apr-2019 | ||
| CA-3134362-A1 | Compositions and methods useable for treatment of dry eye | Pending | 22-Apr-2019 | ||
| EP-3958915-A1 | Compositions and methods useable for treatment of dry eye | Pending | 22-Apr-2019 | ||
| EP-3958915-A4 | Compositions and methods useable for treatment of dry eye | Pending | 22-Apr-2019 | ||
| US-20200345805-A1 | Compositions and methods useable for treatment of dry eye | Inactive | 22-Apr-2019 | A61K38/08 |
Allegro Ophthalmics Signals
Allegro Ophthalmics Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Octane (California) | Accelerator/Incubator | |||
| The Leona M. and Harry B. Helmsley Charitable Trust | Limited Partner | |||
| Bausch Health Companies | Corporation | Minority | ||
| Hanmi Pharm | Corporation | Minority |
Allegro Ophthalmics FAQs
-
When was Allegro Ophthalmics founded?
Allegro Ophthalmics was founded in 2011.
-
Where is Allegro Ophthalmics headquartered?
Allegro Ophthalmics is headquartered in San Juan Capistrano, CA.
-
What is the size of Allegro Ophthalmics?
Allegro Ophthalmics has 6 total employees.
-
What industry is Allegro Ophthalmics in?
Allegro Ophthalmics’s primary industry is Drug Discovery.
-
Is Allegro Ophthalmics a private or public company?
Allegro Ophthalmics is a Private company.
-
What is Allegro Ophthalmics’s current revenue?
The current revenue for Allegro Ophthalmics is .
-
How much funding has Allegro Ophthalmics raised over time?
Allegro Ophthalmics has raised $72.7M.
-
Who are Allegro Ophthalmics’s investors?
Octane (California), The Leona M. and Harry B. Helmsley Charitable Trust, Bausch Health Companies, and Hanmi Pharm have invested in Allegro Ophthalmics.
-
Who are Allegro Ophthalmics’s competitors?
Stuart Therapeutics, Inovio Pharmaceuticals, Kala Bio, ONL Therapeutics, and Foventa Therapeutics are some of the 33 competitors of Allegro Ophthalmics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process